titi
media
inflamm
middl
ear
may
present
either
acut
otiti
media
aom
otiti
media
effus
ome
aom
exhibit
rapidonset
middl
ear
effus
sign
symptom
middl
ear
inflamm
includ
fever
otalgia
otorrhoea
irrit
wherea
ome
middl
ear
effus
absenc
symptom
acut
infect
basi
likelihood
present
treatment
nonindigen
children
aom
may
overreport
wherea
ome
mayb
underreport
recent
prospect
studi
demonstr
frequenc
aom
episod
age
relat
mean
episod
occur
year
among
among
among
older
children
frequenc
newonset
ome
greater
aom
cohort
children
age
year
frequenc
newonset
ome
fourfold
greater
aom
find
consist
previou
data
indic
ome
case
occur
subsequ
aom
otiti
media
upper
respiratori
tract
infect
urti
share
mani
common
symptom
often
coincid
increas
variabl
diagnosi
aom
aom
tempor
associ
urti
coldlik
ill
new
aom
case
case
urti
may
develop
otiti
media
clinic
practic
urti
symptom
either
rhiniti
cough
observ
french
gener
practition
almost
patient
suspect
diagnos
aom
otiti
media
difficult
confirm
otoscop
observ
tympan
membran
chang
includ
bulg
erythema
opac
tympan
membran
alway
characterist
aom
success
otoscop
examin
young
distress
children
often
repeat
occas
increas
diagnost
challeng
clinician
peak
incid
aom
month
age
uncertainti
clinic
diagnosi
aom
demonstr
studi
unit
state
gp
state
certainti
diagnosi
aom
case
among
infant
case
among
toddler
case
among
older
children
furthermor
although
diagnos
aom
children
year
age
shown
consist
gp
otolaryngologist
onethird
incorrect
diagnos
identifi
normal
ear
otolaryngologist
otiti
media
multifactori
diseas
extens
causal
basi
includ
demograph
social
environment
immunolog
microbi
risk
factor
develop
growth
eustachian
tube
first
year
favour
episod
tubal
blockag
often
exacerb
pollut
allergi
viral
infect
abnorm
eustachian
tube
contribut
factor
children
suscept
recurr
episod
aom
ome
equalis
middl
ear
pressur
reopen
eustachian
tube
insuffl
nasopharyng
bacteria
tympan
caviti
import
note
clinic
healthi
middl
ear
may
also
contain
bacteria
evid
bacteri
biofilm
possibl
result
transfer
nasopharynx
normal
event
snif
otiti
media
occur
virus
bacteria
evad
host
mucociliari
immun
respons
inflamm
establish
within
middl
ear
complex
interact
occur
otopathogen
thought
modifi
colonis
dynam
nasopharynx
increas
suscept
otiti
media
aom
sole
associ
virus
caus
urti
case
extent
associ
recent
strengthen
two
prospect
research
studi
healthi
children
incorpor
comprehens
clinic
examin
improv
viral
detect
techniqu
us
research
report
children
age
month
year
experienc
one
urti
per
year
mean
infect
studi
period
nearli
children
age
year
suffer
urti
per
year
otiti
media
identifi
urti
report
children
aom
present
almost
onethird
otiti
media
typic
present
either
acut
otiti
media
aom
symptom
includ
fever
otalgia
otorrhoea
irrit
short
durat
otiti
media
effus
ome
often
asymptomat
characteris
accumul
fluid
middl
ear
diagnost
certainti
otiti
media
challeng
given
young
age
patient
variabl
symptom
otiti
media
predominantli
occur
coincid
viral
upper
respiratori
tract
infect
andor
bacteri
infect
common
virus
caus
upper
respiratori
tract
infect
frequent
associ
aom
newonset
ome
includ
respiratori
syncyti
viru
rhinoviru
adenoviru
parainfluenza
coronaviru
predomin
bacteria
caus
otiti
media
streptococcu
pneumonia
moraxella
catarrhali
nontyp
haemophilu
influenza
antibiot
therapi
significantli
benefit
patient
aom
longterm
prophylact
antibiot
therapi
reduc
risk
otiti
media
recurr
among
children
high
risk
australia
aom
treat
antibiot
therapi
contribut
develop
antibiot
resist
vaccin
develop
key
futur
direct
reduc
world
burden
otiti
media
requir
polymicrobi
formul
ongo
monitor
modif
tit
dia
updat
children
ome
present
almost
quarter
children
children
studi
experienc
mean
episod
aom
per
child
per
year
child
age
strongest
predictor
aom
develop
urti
control
sex
ethnic
recent
prospect
studi
healthi
children
us
confirm
rang
respiratori
virus
causal
urti
highli
coincid
new
episod
otiti
media
aom
newonset
ome
case
coincid
infect
one
upper
respiratori
tract
virus
virus
commonli
coincid
otiti
media
adenoviru
influenza
viru
type
b
respiratori
syncyti
viru
rsv
enteroviru
coronaviru
rhinoviru
parainfluenza
viru
type
interestingli
aom
ome
associ
differ
virus
aom
frequent
associ
coronaviru
rsv
adenoviru
wherea
newonset
ome
occur
influenza
viru
enteroviru
us
research
also
confirm
high
frequenc
associ
otiti
media
rhinoviru
rsv
among
unwel
children
attend
hospit
aom
virus
common
urti
detect
patient
acut
ill
aom
among
children
commonli
identifi
virus
use
viral
cultur
rsv
influenza
type
b
c
combin
adenoviru
improv
viral
detect
also
result
identif
broader
rang
respiratori
virus
includ
human
metapneumonia
viru
coronaviru
bocaviru
causal
either
urti
otiti
media
although
rel
contribut
otiti
media
yet
determin
caution
regard
virus
potenti
associ
otiti
media
urti
necessari
virus
also
detect
children
without
symptom
case
rhinoviru
prolong
period
failur
detect
urti
symptom
aom
episod
otherwis
healthi
children
may
potenti
indic
aom
aros
bacteri
inflammatori
pathogenesi
associ
ome
urti
reflect
observ
newonset
ome
episod
diagnos
day
urti
establish
box
provid
summari
contribut
viral
infect
aom
bacteri
coinfect
upper
respiratori
tract
virus
rather
viral
bacteri
pathogenesi
alon
predomin
report
rang
middl
ear
nasopharynx
three
commonli
recov
bacteria
associ
otiti
media
streptococcu
pneumonia
haemophilu
influenza
moraxella
catarrhali
commens
within
nasopharynx
h
influenza
isol
nontyp
hospitalbas
studi
bacteria
cultur
nasopharyng
secret
middl
ear
fluid
obtain
patient
aom
pneumonia
h
influenza
catarrhali
identifi
nasopharyng
secret
respect
less
frequent
middl
ear
fluid
respect
noncultiv
form
pneumonia
h
influenza
also
stimul
immun
respons
result
ome
occur
nasopharyng
secret
sampl
nasopharyng
colonis
pneumonia
h
influenza
catarrhali
earli
onset
otiti
media
close
correl
nasopharyng
indigen
australian
children
high
risk
otiti
media
colonis
bacteria
staphylococcu
aureu
week
age
children
low
risk
otiti
media
first
episod
aom
involv
pneumonia
h
influenza
catarrhali
peak
first
year
life
aom
caus
peak
incid
month
age
determin
cultur
middl
ear
fluid
contrast
indigen
australian
children
high
risk
otiti
media
experi
high
rate
aom
week
age
tympan
membran
perfor
occur
two
children
studi
overal
nine
indigen
children
age
month
clinic
sign
otiti
media
tympan
membran
perfor
occur
four
children
month
age
unfortun
among
older
children
aom
often
asymptomat
discharg
ear
visibl
otiti
media
high
rate
recurr
three
episod
aom
report
among
children
age
year
rise
children
age
year
age
wherea
ome
recur
children
within
month
indigen
children
high
risk
otiti
media
rate
recurr
aom
ome
better
describ
persist
aom
children
despit
antibiot
treatment
aom
episod
typic
present
acut
onset
short
durat
inde
persist
suppur
remain
present
children
day
initi
diagnosi
first
year
life
case
aom
respond
antibiot
therapi
among
children
aom
may
continu
either
persist
recur
ongo
controversi
whether
ongo
aom
result
persist
earli
clinic
recurr
aom
within
week
initi
treatment
associ
nasopharyng
carriag
pneumonia
although
h
influenza
clearli
associ
recurr
aom
preval
pathogen
observ
bilater
unilater
otiti
media
extens
geograph
variat
observ
bacteri
carriag
diseas
well
pneumococc
serotyp
rel
proport
pneumonia
h
influenza
catarrhali
respons
otiti
media
variat
add
complex
develop
efficaci
vaccin
otiti
media
proport
aom
case
attribut
bacteria
summaris
box
bacteri
biofilm
microbi
commun
attach
mucos
surfac
produc
threedimension
structur
cover
exopolysaccharid
matrix
biofilm
involv
number
otolaryngolog
condit
pneumococc
biofilm
visualis
middl
ear
mucos
biopsi
sampl
children
symptomat
ome
h
influenza
isol
obtain
patient
recurr
aom
form
biofilm
vitro
import
recognis
middl
ear
biofilm
may
present
healthi
ear
without
provok
symptom
biofilm
hypothesis
caus
chronic
suppur
otiti
media
explain
condit
resist
antibiot
treatment
recent
evid
demonstr
pneumococc
biofilm
high
biofilmform
index
exhibit
greater
resist
azithromycin
effect
erad
biofilm
infect
requir
kill
bacteria
destruct
matrix
minimis
persist
viabl
organ
thu
persist
otiti
media
infect
aris
failur
complet
erad
origin
bacteri
infect
presenc
biofilm
intracellular
bacteri
infect
middl
ear
mucos
cell
particularli
mucussecret
cell
immun
respons
middl
ear
infect
characteris
predominantli
inflammatori
respons
normal
result
clearanc
microorgan
middl
ear
caviti
acut
phase
polymicrobi
natur
diseas
explain
least
part
entir
recurr
acut
infect
occur
howev
children
higher
risk
recurr
chronic
diseas
immun
mechan
import
protect
otiti
media
poorli
understood
studi
suggest
children
prone
otiti
media
may
one
sever
immun
perturb
although
none
studi
conclus
respect
causal
linkag
also
suggest
mucos
immun
respons
may
downregul
persist
high
nasopharyng
carriag
otiti
media
develop
often
preced
viral
urti
may
predispos
children
secondari
bacteri
infect
mucos
epitheli
damag
impair
mucociliari
function
upregul
inflammatori
cytokin
respons
adenoid
mucosaassoci
lymphoid
tissu
aid
local
immun
protect
bacteria
virus
local
product
secretori
antibodi
inhibit
antigen
uptak
block
attach
colonis
microb
absenc
lack
secretori
iga
increas
bacteri
adher
epithelia
bacteri
colonis
nasopharynx
therefor
observ
children
prone
otiti
media
may
lower
level
iga
certain
igg
subclass
particularli
unexpect
howev
appear
overal
deficit
antibodi
respons
routin
paediatr
vaccin
effect
immun
respons
viral
urti
depend
induct
number
immunoregulatori
cytokin
interleukin
il
transform
growth
factor
allergyassoci
cytokin
includ
granulocytemacrophag
colonystimul
factor
recent
studi
examin
cytokin
polymorph
demonstr
highproduct
phenotyp
frequent
among
children
new
otiti
media
episod
coincid
rsv
rhinoviru
infect
wherea
low
product
high
product
tumour
necrosi
factor
phenotyp
contribut
otiti
media
risk
rhinoviru
infect
associ
certain
genet
polymorph
tnfa
tolllik
receptor
genotyp
increas
suscept
otiti
media
suggest
characterist
initi
inflammatori
respons
infect
may
crucial
set
cours
recurr
diseas
importantli
number
environment
factor
exposur
cigarett
smoke
breastfeed
may
modifi
genet
risk
australian
therapeut
guidelin
recommend
antibiot
initi
consult
infant
month
age
diagnos
aom
indigen
children
diagnos
aom
howev
given
high
rate
selfresolv
episod
minim
benefit
antibiot
treatment
children
high
risk
develop
complic
prudent
use
antibiot
propos
minimis
rate
develop
antibioticresist
bacteri
strain
typic
wait
watch
approach
use
analgesia
reduc
acut
pain
recommend
children
age
year
low
risk
children
aom
treat
analgesia
alon
recov
day
middl
ear
effus
normal
resolv
within
day
case
resolut
occur
within
week
unfortun
practic
despit
overal
reduct
use
antibiot
australian
gener
practic
overal
rate
antibiot
prescript
aom
children
increas
antibiot
prescrib
case
rise
continu
high
rate
antibiot
prescript
justifi
basi
prophylact
administr
reduc
preval
ome
margin
improv
observ
children
low
risk
children
high
risk
ome
indigen
australian
children
benefit
prophylaxi
show
increas
return
normal
middl
ear
function
reduc
risk
tympan
perfor
pneumococc
carriag
overprescript
antibiot
gener
commun
increas
develop
antibioticresist
pneumonia
clearli
demonstr
recent
studi
tit
dia
updat
show
antibiot
resist
highli
correl
use
antibiot
geograph
across
europ
increas
antibacteri
resist
demonstr
three
common
bacteri
otiti
media
otopathogen
pneumonia
h
influenza
catarrhali
inde
may
negat
small
vaccin
protect
effect
otiti
media
observ
pneumococc
conjug
vaccin
vaccin
futur
otiti
media
polymicrobi
diseas
four
otopathogen
predomin
pneumonia
h
influenza
catarrhali
rsv
henc
vaccin
strategi
initi
direct
microb
pneumonia
vaccin
need
includ
major
serotyp
respons
diseas
current
three
pneumococc
vaccin
avail
polysaccharid
conjug
vaccin
use
nontox
mutant
diphtheria
toxin
carrier
protein
prevenar
wyeth
sydney
nsw
polysaccharid
conjug
vaccin
use
protein
main
carrier
protein
synflorix
glaxosmithklin
melbourn
vic
polysaccharid
formul
pneumovax
merck
sharp
dohm
sydney
nsw
vaccin
primarili
develop
immunis
invas
pneumococc
diseas
pneumovax
shown
rel
efficaci
prevent
invas
pneumococc
diseas
individu
year
age
demonstr
efficaci
use
children
recurr
aom
use
booster
pneumococc
conjug
vaccin
immunis
pneumococc
vaccin
reduc
occurr
aom
episod
perform
better
aom
due
vaccinetyp
pneumococci
reduct
episod
due
serotyp
around
concern
rel
increas
proport
diseas
aris
nonvaccin
serotyp
pneumonia
bacteri
pathogen
newer
vaccin
formul
incorpor
greater
number
pneumonia
serotyp
particularli
one
incorpor
protein
antigen
h
influenza
protein
synflorix
improv
vaccin
efficaci
otiti
media
inde
studi
earlier
vaccin
formul
contain
protein
confer
protect
aom
caus
h
influenza
approxim
case
addit
observ
pneumococc
serotyp
approxim
case
present
vaccin
base
anim
model
studi
possibl
develop
tribacteri
pneumonia
h
influenza
catarrhali
vaccin
futur
beyond
realiti
inclus
viral
compon
futur
polymicrobi
vaccin
come
later
experi
studi
date
suggest
microbi
ecolog
nasopharynx
may
alter
vaccin
particularli
microb
target
often
part
commens
flora
addit
introduct
pneumococc
conjug
vaccin
consequ
decreas
vaccin
serotyp
commonli
resist
antimicrobi
gener
accept
overal
reduct
rate
detect
antibiot
resist
howev
evid
increas
antibiot
resist
nonvaccin
pneumococc
serotyp
could
reduc
overal
impact
pneumococc
conjug
vaccin
antibiot
resist
henc
necessari
establish
ongo
surveil
studi
monitor
chang
otopathogen
profil
continu
prescrib
antibiot
cautious
treatment
otiti
media
otiti
media
occur
frequent
young
young
children
result
infect
middl
ear
bacteria
virus
predomin
bacteria
causal
otiti
media
includ
pneumonia
h
influenza
catarrhali
wherea
virus
commonli
associ
otiti
media
includ
rsv
coronaviru
adenoviru
influenza
viru
excess
use
antibiot
treatment
aom
children
risk
develop
complic
contribut
develop
antimicrobi
resist
howev
earli
prophylact
antibiot
use
benefit
children
high
risk
develop
complic
otiti
media
indigen
australian
children
futur
develop
vaccin
includ
greater
number
pneumococc
serotyp
antigen
h
influenza
catarrhali
need
develop
therapeut
prevent
strategi
complic
bacteria
may
abl
evad
antimicrobi
therapi
host
immun
respons
format
biofilm
capac
resid
intracellularli
middl
ear
mucos
cell
develop
proteinbas
vaccin
antigen
compon
three
predomin
caus
bacteria
common
upper
respiratori
tract
virus
distant
possibl
